ZA727971B - Steroids having anaesthetic activity and pharmaceutical compositions based thereon - Google Patents
Steroids having anaesthetic activity and pharmaceutical compositions based thereonInfo
- Publication number
- ZA727971B ZA727971B ZA727971A ZA727971A ZA727971B ZA 727971 B ZA727971 B ZA 727971B ZA 727971 A ZA727971 A ZA 727971A ZA 727971 A ZA727971 A ZA 727971A ZA 727971 B ZA727971 B ZA 727971B
- Authority
- ZA
- South Africa
- Prior art keywords
- steroids
- pharmaceutical compositions
- compositions based
- anaesthetic activity
- anaesthetic
- Prior art date
Links
- 230000003444 anaesthetic effect Effects 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- 150000003431 steroids Chemical class 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
- C07J5/0007—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa
- C07J5/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond not substituted in position 17 alfa not substituted in position 16
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
- C07J7/0005—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21
- C07J7/001—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group
- C07J7/0015—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa
- C07J7/002—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms not substituted in position 21 substituted in position 20 by a keto group not substituted in position 17 alfa not substituted in position 16
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB5246671A GB1409240A (en) | 1971-11-11 | 1971-11-11 | Anaesthetic steroid of the 5alpha-pregnane series |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA727971B true ZA727971B (en) | 1973-09-26 |
Family
ID=10464023
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA727971A ZA727971B (en) | 1971-11-11 | 1972-11-10 | Steroids having anaesthetic activity and pharmaceutical compositions based thereon |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US3822297A (enExample) |
| JP (1) | JPS4861465A (enExample) |
| AU (1) | AU476623B2 (enExample) |
| BE (1) | BE791196A (enExample) |
| CA (1) | CA992068A (enExample) |
| DE (1) | DE2255153A1 (enExample) |
| DK (1) | DK131296B (enExample) |
| ES (1) | ES408509A1 (enExample) |
| FR (1) | FR2159447B1 (enExample) |
| GB (1) | GB1409240A (enExample) |
| IE (1) | IE37076B1 (enExample) |
| IL (1) | IL40790A (enExample) |
| NL (1) | NL7215225A (enExample) |
| PH (1) | PH9928A (enExample) |
| SE (1) | SE390025B (enExample) |
| ZA (1) | ZA727971B (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3952031A (en) * | 1970-11-12 | 1976-04-20 | Glaxo Laboratories Limited | Anaesthetic composition containing a steroid of the 5α-pregnane series and method of using same |
| DE2438020A1 (de) * | 1974-08-05 | 1976-02-26 | Schering Ag | 18-methyl-19-nor-20-keto-pregnane und verfahren zu ihrer herstellung |
| US5232917A (en) * | 1987-08-25 | 1993-08-03 | University Of Southern California | Methods, compositions, and compounds for allosteric modulation of the GABA receptor by members of the androstane and pregnane series |
| AUPN498095A0 (en) * | 1995-08-23 | 1995-09-14 | Goodchild, Colin Stanley | Compounds and compositions |
| US6787530B1 (en) | 1996-08-23 | 2004-09-07 | Monash University | Use of pregnane-diones as analgesic agents |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| FR1281205A (fr) * | 1956-12-21 | 1962-01-12 | Organon Nv | Procédé d'obtention de composés de la série du prégnane |
-
0
- BE BE791196D patent/BE791196A/xx unknown
-
1971
- 1971-11-11 GB GB5246671A patent/GB1409240A/en not_active Expired
-
1972
- 1972-11-10 FR FR7239866A patent/FR2159447B1/fr not_active Expired
- 1972-11-10 CA CA156,153A patent/CA992068A/en not_active Expired
- 1972-11-10 ES ES408509A patent/ES408509A1/es not_active Expired
- 1972-11-10 DE DE2255153A patent/DE2255153A1/de not_active Ceased
- 1972-11-10 IL IL40790A patent/IL40790A/xx unknown
- 1972-11-10 AU AU48754/72A patent/AU476623B2/en not_active Expired
- 1972-11-10 ZA ZA727971A patent/ZA727971B/xx unknown
- 1972-11-10 SE SE7214660A patent/SE390025B/xx unknown
- 1972-11-10 IE IE1541/72A patent/IE37076B1/xx unknown
- 1972-11-10 US US00305245A patent/US3822297A/en not_active Expired - Lifetime
- 1972-11-10 JP JP47112189A patent/JPS4861465A/ja active Pending
- 1972-11-10 DK DK559072AA patent/DK131296B/da unknown
- 1972-11-10 NL NL7215225A patent/NL7215225A/xx not_active Application Discontinuation
- 1972-12-10 PH PH14065A patent/PH9928A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| DK131296C (enExample) | 1975-11-17 |
| IE37076B1 (en) | 1977-04-27 |
| BE791196A (fr) | 1973-05-10 |
| CA992068A (en) | 1976-06-29 |
| AU476623B2 (en) | 1976-09-30 |
| JPS4861465A (enExample) | 1973-08-28 |
| DE2255153A1 (de) | 1973-05-24 |
| IL40790A (en) | 1975-05-22 |
| US3822297A (en) | 1974-07-02 |
| DK131296B (da) | 1975-06-23 |
| IL40790A0 (en) | 1973-01-30 |
| FR2159447B1 (enExample) | 1976-08-20 |
| IE37076L (en) | 1973-05-11 |
| FR2159447A1 (enExample) | 1973-06-22 |
| AU4875472A (en) | 1974-05-16 |
| GB1409240A (en) | 1975-10-08 |
| ES408509A1 (es) | 1976-05-01 |
| SE390025B (sv) | 1976-11-29 |
| PH9928A (en) | 1976-06-14 |
| NL7215225A (enExample) | 1973-05-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KE2755A (en) | New phenoxy-alkyl-carboxylic acid derivatives and the preparation thereof | |
| NZ179495A (en) | 1-substituted-4-benzylpiperidines and pharmaceutical compositions | |
| GB1403003A (en) | Oxoazetidine derivatives and preparation thereof | |
| IL39988A0 (en) | Pyrazolopyrimidines and pharmaceutical compositions containing them | |
| HK28382A (en) | Photopolymerizable compositions and their use | |
| IE35991L (en) | Camphor-containing pharmaceutical composition | |
| ZA728177B (en) | Pharmaceutical devices and methods | |
| ZA726638B (en) | New phenoxy-alkyl-carboxylic acid derivatives and the preparation thereof | |
| CA1010847A (en) | Compounds of the pregnane series having useful anaesthetic activity and processes for their preparation | |
| AU3450471A (en) | Pharmaceutical and veterinary compositions | |
| ZA727971B (en) | Steroids having anaesthetic activity and pharmaceutical compositions based thereon | |
| ZA726271B (en) | New phenylimino-3-aza-1-thia-cycloalkanes their preparation and their medicinal use | |
| AU4775772A (en) | Compositions and processes | |
| ZA718327B (en) | Pharmaceutical composition | |
| ZA722077B (en) | Veterinary and pharmaceutical compositions | |
| GB1403550A (en) | 3-carbamoyl-3-hyeroxy-4-halobutyric acid and the preparation thereof | |
| ZA713249B (en) | Therapeutic process and compositions | |
| MY7700129A (en) | Pharmaceutical and veterinary compositions for the treatment of hyperlipoproteinaemia | |
| CA988508A (en) | Steroids having useful anaesthetic activity and processes for their preparation | |
| ZA72505B (en) | N-acyl-(piperazinoalkyl)-pyrazoles and their preparation | |
| PH11404A (en) | 2(n-substituted-phenylamino)-imidazolines-(2)and pharmaceutical compositions thereof | |
| IE34921L (en) | Pharmaceutical and dietetic composition | |
| IL38964A0 (en) | Novel steroids of the androstane series,their preparation and pharmaceutical compositions containing them | |
| GB1400842A (en) | Oxaprostanoic acid derivatives and pharmaceutical compositions containing the same | |
| IL37236A0 (en) | New cardenolides and bufadienols pharmaceutical compositions them |